Biotheus has established a next-generation pipeline for treating cancer and inflammatory diseases. We have formed strategic collaborations with top-quality academic and industry partners in order to create an exciting and differentiating pipeline covering promising drug targets and modalities. At this stage, we are actively seeking partners to help advance Biotheus' broad pipeline into late-stage clinical phases towards their commercialisation.